Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GR205171 in PTSD
NCT00383786Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing GR205171 with Placebo (2 arms). Primary endpoint: Changes in Clinician-Administered PTSD Scale Scores at 8 weeks. Started Sep 2006; status: completed.
02
Drugs
vofopitant
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00383786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383786.